nubeqa
bayer ag - darolutamide - stækkun Æxli, gelding-Þola - innkirtla meðferð - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.
neptra
bayer animal health gmbh - florfenicol, terbinafin stutt og long-term, mometasone furoate - otologicals, krefur og antiinfectives í samsetning - hundar - fyrir meðferð bráð hundur bólgu í ytra eða bráð tilvikum endurtekin eyrnabólga af völdum blandað sýkingar næm stofnum bakteríur viðkvæm florfenicol (Þegar pseudintermedius) og sveppi viðkvæm terbinafin (malassezia pachydermatis).
kyleena leginnlegg 19.5 mg
bayer a/s* - levonorgestrelum inn - leginnlegg - 19.5 mg
primovist stungulyf, lausn í áfylltri sprautu 0,25 mmól/ml
bayer ab - sodium gadoxetate - stungulyf, lausn í áfylltri sprautu - 0,25 mmól/ml
baycoxine vet (baycox multi) mixtúra, dreifa 50 mg/ml
bayer animal health gmbh - toltrazurilum inn - mixtúra, dreifa - 50 mg/ml
seresto vet. lyfjahálsól 1,25 g / 0,56 g
bayer animal health gmbh - imidaclopridum inn; flumethrin - lyfjahálsól - 1,25 g / 0,56 g
seresto vet. lyfjahálsól 4,5 g / 2,03 g
bayer animal health gmbh - imidaclopridum inn; flumethrin - lyfjahálsól - 4,5 g / 2,03 g
canesten krem 10 mg/g
bayer ab - clotrimazolum inn - krem - 10 mg/g
canesten leggangatafla 100 mg
bayer ab - clotrimazolum inn - leggangatafla - 100 mg
canesten leggangatafla 500 mg
bayer ab - clotrimazolum inn - leggangatafla - 500 mg